This article originally posted 20 July, 2009 and appeared in Issue 478
Miscelaneous Issue 478
Tool for Your Practice:
Know your A1c is a chart that shows your A1c and how it relates to your average blood sugars. Know your A1c
Tolerx Phase 3 Study: DEFEND is a Phase 3 clinical study of otelixizumab in YOUNG ADULTS with newly diagnosed T1DM. Otelixizumab is an investigational agent, not yet approved by the FDA for marketing. DEFEND will determine if otelixizumab can help preserve the ability to make endogenous insulin and stop the destruction of the body's cells that make insulin (beta cells). You can find out more at: www.defendagainstdiabetes.com
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2013 Diabetes In Control, Inc.. All rights reserved.
Know your A1c is a chart that shows your A1c and how it relates to your average blood sugars. 
